Neurological products and therapies newsLatest articles Renishaw becomes one of the first neurosurgical solutions providers to be granted MDR product approval Renishaw announces completion of clinical trial extension study, using its innovative drug delivery system in the investigation of CDNF as a treatment for Parkinson's disease Renishaw announces completion of the main part of a multi-centre clinical trial Renishaw promotes robotic stereoelectroencephalography (SEEG) at ILAE Renishaw’s neuroinfuse™ drug delivery system shortlisted for Healthcare Award All articles NewsCompany newsMachine calibration and optimisationCMM probes, software and retrofitsPosition encodersGauging NewsMachine tool automationRaman spectroscopyNeurological products and therapiesAdditive manufacturingFinancial news and results Corporate informationAbout RenishawNewsMedia hubEventsInvestor relations